DDI Flashcards

1
Q

examples of prodrugs

A

codeine – morphine
clopidogrel
prednisone – prednisolone
tramadol
valacyclovir – acyclovir
levodopa – DA
cortisone – cortisol
prmodone – phenobarbital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

codeine is activated by CYP____

A

2D6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

hypermetabolizers of 2D6 will have ________ concentrations of morphine after taking codeine

slow metabolizers of 2D6 will have ______ concentrations of morphing after codeine admin

A

HMs will have higher morphine concentrations and increased risk of toxicity

slow metabolizers will have dec concentrations of morphine and have poor analgesic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

clopidogrel is metabolized by CYP____

A

2C19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is p-gp? what happens if it induced/inhibited)

A

p-gp effluxes drugs from the bloodstream back into the gut to be excreted in stool
inhibit pgp –> inc Cp of substrate
induce pgp –> dec Cp of substrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

common p-gp substrates

A

DOACs
dig, dilt, verapamil, cervedilol
cyclosporine and tacro

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

common p-gp inducers

A

carbamazepine
phenobarb
pnehytoin
rifampin
SJ Wort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

common inhbitors of pgp

A

clarithro
itraconazole, posaconazole
amiodarone
dilt
verapamil
cobicistat, ritonavir
cyclosporine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is enterohepatic recycling

A

drugs are metabolized in the liver then transported, through bile, back to the gut where drug can be reabsorbed, enter portal vein and go back to the liver
this increases duration of action of some drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what drugs undergo enterohepatic recycling

A

ABX
NSAIDs
zetia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

amiodarone and warfarin DDI? How do we adjust dose(s)

A

w is a 2C9 substrate
a inhibits 2C9 causing inc Cp warfarin

if ADDING warfarin to a, start warfarin at low dose </= 5mg
if ADDING a to warfarin, dec warfarin dose 30-50%
monitor INR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

amiodarone and digoxin DDI? How do we adjust dose(s)

A

amiodarone inhibits p-gp
dig is a p-gp substrate and amio will inc Cp when given together
if adding digoxin : start at 0.125mg daly
if adding amio: dec dig dose 50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DDI between digoxin and loops
how to monitor

A

loops dec K, Na, Mg, Ca
digoxin toxicity is increased w/ dec K and Mg and inc Ca ESPECIALLY in renal imp

monitor electrolytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

statins and 3A4-i

A

lovastatin, simvastatin and atorvastatin are 3A4 substrates
3A4-i increase statin concentration and increase risk for rhabdo, AKI and myopathy

simva and lova are CI with strong 3A4-i

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

warfarin and 2C9 DDI

A

S-warfarin is metabolized by 2C9 and can be the cause of many DDI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

which opioids are metabolized by 3A4?

A

fentanyl
oxycodone
hydrocodone
methadone

all CI with strong 3A4-i

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

VPA and lamictal DDI? How do we adjust dose(s)

A

VPA inhibits lamictal metabolism and increases Cp of lamictal which increases risk of toxicity including SJS/TEN

titrate lamictal very slowly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what does MAO metabolize

A

NE
DA
5-HT
tyramine
EN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

inhibiting MAO will increase its substrates NE, EN, DA and tyramine leading to _____

A

hypertensive crisis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

MAO-i examples

A

linezolid
selegeline
rasageline
methylene blue
isocarboxazid
tranylcypromine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

MAO-is are of concern with which types of medications/substances

A

serotinergics
tyramine foods
sympathomimetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what are the major 2D6 substrates

A

codeine
meperidine
tramadol
tamoxifen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

how does rifampin usually contribute to DDI

A

strong p-gp and CYP inhibitor

24
Q

how does smoking contribute to DI

A

induces 1A2 and 2C9

25
Q

which drugs can contribute to serotonin toxicity

A

SSRI
SNRI
SRI
MAO-i
methadone, fentanyl, meperidine, tramadol
SJ wort
triptans
buspirone
lithium
linezolid
methylene blue

26
Q

drugs that contribute to bleed risk

A

anticoags
NSAIDs
SSRI/SNRI
antiplatelets

teh 5G’s!
ginseng
ginger
ginko balboa
glucosamine
garlic

27
Q

medications/conditions that contribute to hyperkalemia

A

KCl
RAAS-i
SMX/TMP
CN-i (tacro)
K-sparing diuretics (amiloride, triamterene, spironolactone)
canagliflozin
drosperinone in OCs
renal impairment!!!

28
Q

medications that contribute to QT prolongation

A

5 A’s!

Antiarrhythmics
Anti-infectives: macrolides, FQs, azoles, antimalarials
ADs: trazodone, mirt, SSRI (escit, cit), venlafaxine, TCAs
APs: ziprasidone», 1st genes
Antiemetics: 5HT3 RAs, metoclopramide, promethazine, droperidol

others: loperamide, methadone

29
Q

methadone places patients at risk of

A

serotonin syndrome and QT prolongation

30
Q

CNS depressants

A

opioids
benzos
sk m relaxants
barbiturates
hypnotics
antihistamines
alcohol
cough syrups
cannabinoids (dronabinol)
mirtazepine
trazodone

31
Q

ototoxins

A

vancomycin
AGs
cisplatin
loops
salicylates

32
Q

nephrotoxins

A

NSAIDs
vanco
AGs
loops
radiographic contrast dye
Amph B
polymixins
CN-i (tacro, siro)
cisplatin

33
Q

how do we prevent cisplatin-induced nephrotoxicity

A

use amifostine and fluids

34
Q

orthostasis risk medications

A

PDE-5 -i
alpha blockers (flomax, doxazosin, terazosin)
nitrates

35
Q

3A4 substrates

A

opioids fentanyl, oxycodone, hydrocodone, methadone, bup, tramadol
DOACs, warfarin
amiodarone, amlodipine, dilt, verap
atorv, simva, lova - statin
NNRTIs
PDE5-i
ethanyl estradiol

36
Q

3A4 inducers

A

carbamazepine
phenobarbital
phenytoin
SJW
rifampin

37
Q

3A4 inhibitors

A

clarithro, erythro
isoniazid
azoles
amodarone
diltiazem
verapamil
cobicistat
ritonavir
protease-i (-navir)
grapefruit
cyclosporine

38
Q

CYP2C8 substrates

A

amiodarone
pioglitazone
repaglinide

39
Q

CYP2C8 inducers

A

phenytoin
rifampin

40
Q

CYP2C8 inhibitors

A

amiodarone
clopidogrel
ketoconazole
SMX/TMP

41
Q

CYP2D6 substrates

A

codeine, meperidine, tramadol
APs
doxepin
trazodone
TCAs
ADs

tamoxifen
carvedilol
metoprolol
propranolol

42
Q

CYP2D6 inducers

A

none

43
Q

CYP2D6 inhibitors

A

amiodarone
duloxetine
fluoxetine
paroxetine
bupropion
cobicistat

44
Q

CYP2C9 substrates

A

S-warfarin!!!!!
carvedilol
diazepam
SUs
phenytoin
tamoxifen
zolpidem

45
Q

CYP2C9 inducers

A

smoking

carbamazepine
phenobarbital
phenytoin
rifampin
SJW

46
Q

CYP2C9 inhibitors

A

amiodarone
fluuconazole
metronidazole
ketoconazole
voriconazole
VPA
TMP/SMX

47
Q

tramadol therapy concerns

A

prodrug
2D6 and 3A4 substrate
serotinergic

48
Q

trazodone therapy concerns

A

QTp
CNS depressant
2D6 substrate

49
Q

azoles cause DDI by_________________

A

3A4 and 2C9 inhibition

50
Q

CYP2C19 substrates

A

clopidogrel!!!
phenytoin

51
Q

CYP2C19 inducers

A

phenobarbital
phenytoin
rifampin
carbamazepine

52
Q

CYP2C19 inhibitors

A

esomeprazole
omeprazole

53
Q

CYP1A2 substrates

A

R-warfarin
theophylline
some APs
hypnotics
anxiolytics
ADs

54
Q

CYP1A2 inducers

A

smoking
phenobarbital
phenytoin
rifampin
carbamazepine

55
Q

CYP1A2 inhibitors

A

fluvoxamine
ciprofloxacin

56
Q

what are the common inducers and what CYPs do they induce

A

phenobarbital
phenytoin
rifampin
carbamazepine

3A4, 2C9, 2C19, 1A2

phenytoin and rifampin induce 2C8